Perspective Therapeutics (CATX) Retained Earnings (2011 - 2026)

Perspective Therapeutics has disclosed Retained Earnings across 16 years of filings, most recently posting -$361.0 million for Q1 2026.

• Retained Earnings for Q1 2026 came in at -$361.0 million, down 44.47% year-over-year; the trailing twelve-month figure through Mar 2026 was -$361.0 million (down 44.47% YoY), and the FY2025 annual result was -$334.8 million, down 656449.02% from the prior year.
• Retained Earnings came in at -$361.0 million for Q1 2026 at Perspective Therapeutics, down from -$334.8 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of -$51000.0 in Q4 2024 to a low of -$361.0 million in Q1 2026.
• The 5-year median for Retained Earnings is -$152.4 million (2023), against an average of -$173.8 million.
• Across the five-year window, Retained Earnings soared 99.97% in 2024 and slumped 656449.02% in 2025, its largest moves.
• Perspective Therapeutics' Retained Earnings stood at -$105.9 million in 2022, then slumped by 43.9% to -$152.4 million in 2023, then jumped by 99.97% to -$51000.0 in 2024, then plunged by 656449.02% to -$334.8 million in 2025, then retreated by 7.82% to -$361.0 million in 2026.
• The last three Retained Earnings figures came in at -$361.0 million (Q1 2026), -$334.8 million (Q4 2025), and -$297.3 million (Q3 2025), per Business Quant data.